Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization

ClinicalTrials.gov ID: NCT00288418

Public ClinicalTrials.gov record NCT00288418. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 3:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Controlled, Randomized, Single-Blind, Multi-Center Pivotal Clinical Study Using Angiotech CVC to Prevent Bacterial Colonization on Short-Term Central Venous Catheters

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to determine if the Angiotech central venous catheter (CVC) is equal in effectiveness to a CVC coated with chlorhexidine and silver sulfadiazine in preventing bacterial catheter colonization. Other objectives of this study are to determine if the Angiotech CVC is equal in effectiveness to a CVC coated with chlorhexidine and silver sulfadiazine in preventing catheter-related local infection, and catheter-related bloodstream infection. This study will also assess the safety of the Angiotech CVC.

Study identification

NCT ID
NCT00288418
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Angiotech Pharmaceuticals
Industry
Enrollment
960 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2005 (Type not available)
Primary completion
Jul 2007 (Actual)
Completion
Jul 2007 (Actual)
Last update posted
Jan 23, 2013

2005 – 2007

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
20
Facility City State ZIP Site status
Cardio-Thoracic Surgeons, P.C. Birmingham Alabama 35235 —
Pulmonary Consultant Group Orange California 92868 —
Pulmonary Center Sharp Memorial Hospital San Diego California 92123 —
Kaiser Permanente Santa Teresa San Jose California 95119 —
Denver Health Medical Center Denver Colorado 80204 —
Christiana Care Research Institute Newark Delaware 19713 —
Florida Research Network, LLC Gainesville Florida 32605 —
Atlanta Institute for Medical Research Inc Decatur Georgia 30030 —
Kerry Thibodeaux, M.D. Opelousas Louisiana 70570 —
UMASS Medical School, Dept of Anesthesiology Worcester Massachusetts 01655 —
Newark Beth Israel Hospital Newark New Jersey 07112 —
Pulmonary and Critical Care Medicine Cincinnati Ohio 45267 —
St Vincent Mercy Medical Center, Bldg 1 Toledo Ohio 43608 —
Medical University of Ohio Toledo Ohio 43614 —
Universty of Oklahoma HSC Oklahoma City Oklahoma 73104 —
Drexel University College of Medicine Philadelphia Pennsylvania 19102 —
Rhode Island Hospital Providence Rhode Island 02903 —
Rapid City Regional Hospital Rapid City South Dakota 57701 —
University of Virginia, Department of Anesthesiology Charlottesville Virginia 22908 —
Winchester Medical Center Winchester Virginia 22601 —
Franciscan Health System Research Center Tacoma Washington 98405 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00288418, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 23, 2013 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00288418 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →